alpha-glycerophosphoric acid has been researched along with metformin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cai, Z; Deng, Y; Feng, Y; Han, Z; Jiang, F; Liang, Y; Liu, R; Luo, Y; Mo, R; Wu, CL; Wu, Y; Xie, J; Ye, J; Zheng, Y; Zhong, W; Zhu, J; Zhu, X; Zhuo, Y | 1 |
2 other study(ies) available for alpha-glycerophosphoric acid and metformin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Growth Processes; Cell Line, Tumor; Cell Respiration; Drug Synergism; Glycerolphosphate Dehydrogenase; Glycerophosphates; HCT116 Cells; Heterografts; Humans; Male; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasms; PC-3 Cells; Reactive Oxygen Species; RNA, Messenger | 2020 |